Search Results
Final OS results from PAOLA-1 evaluating 1L maintenance olaparib plus bevacizumab
Selecting patients to be treated with maintenance olaparib in the PAOLA-1 trial
PAOLA-1 Phase 3 data: olaparib plus bevacizumab maintenance for advanced ovarian cancer
PAOLA-1: Combination Maintenance Therapy in Ovarian Cancer
The Impact of PAOLA-1 on Frontline Treatment of Ovarian Cancer
#ESMO19: Positive Trial for Ovarian Cancer: PAOLA-1/ENGOT-ov25
7-year OS from SOLO1: sustained benefit with maintenance olaparib
Maintenance Therapy: NCCN Guidelines, PAOLA-1 Trial
Expert report on survival data from pivotal trials with PARP inhibitors for BRCA-mut. Ovarian Cancer
The potential of PARP inhibitors in ovarian cancer: PAOLA-1, PRIMA & VELIA
PARP + Maintenance Bevacizumab in Ovarian Cancer
SOLO1: 7-Year Follow-up Highlights the Value of Maintenance Olaparib